ArticleExperimental brain research2025
Galvanic vestibular stimulation for Mal de Debarquement syndrome: a pilot study on therapeutic potential.
Article in Experimental brain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Mal de Debarquement Syndrome (MdDS) is a debilitating neuro-otological disorder causing a persistent sensation of self-motion, often triggered by passive motion like being on a boat (MT-MdDS) or non-motion triggered (non-MT MdDS). Due to the unknown pathophysiological mechanism, available treatment options for managing symptoms are limited. Within the framework of a pilot study, our objective was to investigate the effect, safety, and feasibility of galvanic vestibular stimulation (GVS) as a potential alternative treatment option for MdDS. The trial included 12 MdDS patients and 12 controls. In Part 1, the perceptual threshold for movement perception was determined using both sine and noisy (white noise) GVS for both patients and controls. In Part 2, patients received up to eight four-minute GVS at varying intensities, determined by their individual threshold, during both sine and noisy GVS (i.e., at their threshold, 120%, 70%, and 20%). The effectiveness was evaluated using visual analogue scale (VAS) scores and static posturography. Five patients reported improvement with noisy GVS at 70%, two at noisy threshold, one at noise 20%, one at 120%, one at sine 20%, and one at sine 120%. Our findings show statistically significant positive trends in both subjective and objective outcome measures following specific GVS sessions. Particularly, notable improvements were observed with noisy GVS at intensities 70% and 20% below perceptual threshold levels. All patients found GVS to be safe and manageable, with no worsening of their symptoms. GVS demonstrated positive trends in posturographic stability, particularly with 70% currents and noisy GVS. While further research is necessary, the potential benefits, safety, and feasibility of GVS for MdDS patients have been demonstrated as promising.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.